JP2017523230A5 - - Google Patents

Download PDF

Info

Publication number
JP2017523230A5
JP2017523230A5 JP2017508099A JP2017508099A JP2017523230A5 JP 2017523230 A5 JP2017523230 A5 JP 2017523230A5 JP 2017508099 A JP2017508099 A JP 2017508099A JP 2017508099 A JP2017508099 A JP 2017508099A JP 2017523230 A5 JP2017523230 A5 JP 2017523230A5
Authority
JP
Japan
Prior art keywords
mixture
composition
acid
present
comprised
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017508099A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017523230A (ja
JP7118642B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2015/055885 external-priority patent/WO2016020828A1/en
Publication of JP2017523230A publication Critical patent/JP2017523230A/ja
Publication of JP2017523230A5 publication Critical patent/JP2017523230A5/ja
Priority to JP2020172613A priority Critical patent/JP7335475B2/ja
Application granted granted Critical
Publication of JP7118642B2 publication Critical patent/JP7118642B2/ja
Priority to JP2023012916A priority patent/JP2023041806A/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017508099A 2014-08-08 2015-08-03 炎症性およびアレルギー性病変の治療に用いるための脂肪酸とパルミトイルエタノールアミドの混合物 Active JP7118642B2 (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2020172613A JP7335475B2 (ja) 2014-08-08 2020-10-13 炎症性およびアレルギー性病変の治療に用いるための脂肪酸とパルミトイルエタノールアミドの混合物
JP2023012916A JP2023041806A (ja) 2014-08-08 2023-01-31 炎症性およびアレルギー性病変の治療に用いるための脂肪酸とパルミトイルエタノールアミドの混合物

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITMI2014A001474 2014-08-08
ITMI20141474 2014-08-08
PCT/IB2015/055885 WO2016020828A1 (en) 2014-08-08 2015-08-03 Mixture of fatty acids and palmitoylethanolamide for use in the treatment of inflammatory and allergic pathologies

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2020172613A Division JP7335475B2 (ja) 2014-08-08 2020-10-13 炎症性およびアレルギー性病変の治療に用いるための脂肪酸とパルミトイルエタノールアミドの混合物

Publications (3)

Publication Number Publication Date
JP2017523230A JP2017523230A (ja) 2017-08-17
JP2017523230A5 true JP2017523230A5 (enExample) 2018-05-17
JP7118642B2 JP7118642B2 (ja) 2022-08-16

Family

ID=51663273

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2017508099A Active JP7118642B2 (ja) 2014-08-08 2015-08-03 炎症性およびアレルギー性病変の治療に用いるための脂肪酸とパルミトイルエタノールアミドの混合物
JP2020172613A Active JP7335475B2 (ja) 2014-08-08 2020-10-13 炎症性およびアレルギー性病変の治療に用いるための脂肪酸とパルミトイルエタノールアミドの混合物
JP2023012916A Ceased JP2023041806A (ja) 2014-08-08 2023-01-31 炎症性およびアレルギー性病変の治療に用いるための脂肪酸とパルミトイルエタノールアミドの混合物

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2020172613A Active JP7335475B2 (ja) 2014-08-08 2020-10-13 炎症性およびアレルギー性病変の治療に用いるための脂肪酸とパルミトイルエタノールアミドの混合物
JP2023012916A Ceased JP2023041806A (ja) 2014-08-08 2023-01-31 炎症性およびアレルギー性病変の治療に用いるための脂肪酸とパルミトイルエタノールアミドの混合物

Country Status (13)

Country Link
US (2) US9962355B2 (enExample)
EP (1) EP3177281B1 (enExample)
JP (3) JP7118642B2 (enExample)
CN (1) CN106714792A (enExample)
CA (1) CA2957700C (enExample)
CO (1) CO2017001088A2 (enExample)
DK (1) DK3177281T3 (enExample)
ES (1) ES2976095T3 (enExample)
FI (1) FI3177281T3 (enExample)
IL (1) IL250271B2 (enExample)
MA (1) MA40417A (enExample)
TW (1) TWI727926B (enExample)
WO (1) WO2016020828A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2016334086B2 (en) * 2015-10-07 2022-10-20 Cormedix Inc. Skin-penetrating formulation of taurolidine
CN109893520A (zh) * 2019-03-21 2019-06-18 中国科学院水生生物研究所 螺旋藻γ-亚麻酸的新用途
AU2020260090C9 (en) * 2019-04-15 2023-08-31 Metagenics LLC Novel hemp and PEA formulation and its use
JP2023542340A (ja) * 2020-09-21 2023-10-06 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 代謝物の免疫学的作用
IT202100024464A1 (it) * 2021-09-23 2023-03-23 Epitech Group S P A N-palmitoil-etanolamide e acido docosaesaenoico per l’uso nel trattamento del disturbo dello spettro autistico e di altre sindromi depressive
CN114209683A (zh) * 2021-12-22 2022-03-22 中南大学湘雅三医院 壬二酸在制备治疗炎症性肠病药物中的应用
KR20240164914A (ko) * 2022-03-14 2024-11-21 페라 다이아그노스틱스 앤드 바이올로지컬스 코프. 지방산 조성물

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1252865B (it) * 1991-12-31 1995-06-28 Lifegroup Spa N-acilderivati di aminoalcooli attivi come autocoidi locali ed utilizzabili nella terapia dei processi autoimmuni
US5679667A (en) * 1992-04-24 1997-10-21 Lifegroup S.P.A. Aminoalcohols-N-Acyl derivatives as therapeutical agents against the neurogenic endoneural edema of the peripheral nerve
IT1257697B (it) * 1992-04-24 1996-02-01 Lifegroup Spa N-acil derivati di aminoalcooli come agenti terapeutici attivi sull'edema neurogenico endoneurale a livello del nervo periferico.
KR0179393B1 (ko) 1992-06-19 1999-03-20 린다 에스. 스티븐슨 표피 보습화 및 장벽 기능 치유용 지질
EP0620000A3 (de) * 1992-12-18 1994-11-02 Rhone-Poulenc Rorer Gmbh Kosmetische und/oder pharmazeutische Verwendung von N-Acylalkanolaminen
US5599548A (en) * 1995-05-08 1997-02-04 Elizabeth Arden Co., Division Of Conopco, Inc. Skin care compositions containing fatty acid amides and retinol or retinyl ester
US5716627A (en) * 1996-04-25 1998-02-10 Elizabeth Arden Co., Division Of Conopco, Inc. Skin care compositions containing fatty acid amides, azoles, and retinol or retinyl ester
JP2000159668A (ja) * 1998-11-26 2000-06-13 Nof Corp サイトカイン抑制剤
JP2000191525A (ja) * 1998-12-25 2000-07-11 Nof Corp 皮膚外用剤組成物
GB9923738D0 (en) * 1999-10-07 1999-12-08 Nestle Sa Nutritional composition
US20020143059A1 (en) * 2000-12-28 2002-10-03 Sreekumar Pillai Skin care product containing retinoids, retinoid booster and phytoestrogens in a dual compartment package
DE10217131A1 (de) * 2001-07-31 2003-02-13 Kuhs Kosmetik Gmbh & Co Kg Topisch applizierbare Zusammensetzung sowie Werkstoffgemisch
ES2344920T3 (es) * 2006-03-28 2010-09-09 Epitech Group S.R.L. Composicion farmaceutica para el tratamiento de patologias provocadas por la respuesta general del sistema inmutario.
NZ552238A (en) * 2006-12-20 2009-07-31 Seperex Nutritionals Ltd An extract
ES2610880T3 (es) 2008-02-22 2017-05-03 Rigel Pharmaceuticals, Inc. Uso de 2,4-pirimidinadiaminas para el tratamiento de la aterosclerosis
DE202008007621U1 (de) 2008-06-04 2008-11-06 Zimmer, Bruno Kosmetisches und Nahrungsmittel aus unterschiedlichen Fettsäuren
AU2011223730A1 (en) * 2010-03-02 2012-10-18 Imagenetix, Inc. Compositions comprising myristic acid and uses thereof
US8618095B2 (en) 2010-04-13 2013-12-31 Rigel Pharmaceuticals, Inc. 2, 4-pyrimidinediamine compounds and prodrugs thereof and their uses
ITMI20111284A1 (it) 2011-07-11 2013-01-12 Giovanni Nusca Composizione farmaceutica.
WO2013171316A1 (en) 2012-05-18 2013-11-21 Sanofi Pyridine derivatives and their use in the treatment of conditions associated with pathological thrombus formation
ITMI20130354A1 (it) * 2013-03-08 2014-09-09 Again Life Italia Srl Miscela di acidi grassi (f.a.g. fatty acids group) per uso nel trattamento di patologie infiammatorie.
CN103242262A (zh) * 2013-05-24 2013-08-14 厦门大学 N-脂肪酰基乙醇胺水解酶抑制剂及其合成方法和用途

Similar Documents

Publication Publication Date Title
JP2017523230A5 (enExample)
IL250271B2 (en) A mixture of fatty acids and palmitoylethanolamide for use in the treatment of inflammatory and allergic pathologies
HRP20200394T1 (hr) Smjesa masnih kiselina (gmk, grupa masnih kiselina) za primjenu u liječenju inflamatornih patologija
JP2016135810A5 (enExample)
JP2016535777A5 (enExample)
AR082024A1 (es) Formulacion de anticuerpo contra ox40l humano
JP2015527386A5 (enExample)
HRP20151039T1 (hr) Upotreba omega masnih kiselina za lijeäśenje bolesti
JP2015531344A5 (enExample)
JP2013515742A5 (enExample)
JP2018522854A5 (enExample)
RU2018136872A (ru) Композиции, содержащие 15-oh эпк, и способы их применения
RU2016106829A (ru) Применение ингибиторов ацетил-СоА карбоксилазы для лечения обыкновенных угрей
JP2017529377A5 (enExample)
JP2014513710A5 (enExample)
EP3706733B1 (en) Substances and compositions for the use in the treatment of endometriosis and endometriosis associated symptoms
US20200138776A1 (en) Composition for use in the treatment of endometriosis and symptoms associated with endometriosis
JP2019521134A (ja) 性感染症用組成物
Freedman et al. LCPUFAs in pregnancy lower offspring's risk for asthma/my take
CA2856014C (en) Combined use of amides of mono- and dicarboxylic acids and silymarin in the treatment of renal diseases
EP2086585A2 (en) Composition for a pharmaceutical treatment based on triethyl citrate and adapalene
ITMI20142077A1 (it) Miscela di acidi grassi (f.a.g. fatty acids group) per uso nel trattamento di patologie infiammatorie
RU99106551A (ru) Применение арахидоновой кислоты и/или докозагексаеновой кислоты для получения лекарства для лечения диспраксии
TH10660C3 (th) สูตรยาสำเร็จรูปชนิดใหม่ (A novel medicament) สำหรับการรักษาการติดเชื้อที่โพรงประสาทฟัน
KR20100087441A (ko) 분만 젤주사기